Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

Low-intensity light therapy is effective for skin healing, reducing inflammation, and treating various skin conditions.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Dermal fibroblasts have adjustable roles in wound healing, with specific cells promoting regeneration or scar formation.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

Plant-derived vesicles from Ayurvedic plants may improve treatment delivery for hair growth and other conditions.

Araliadiol may help reduce skin aging and inflammation without killing cells.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Ethosomes enhance skin penetration better than liposomes, benefiting therapeutic and cosmetic applications.

Nilotinib can cause generalized keratosis pilaris.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Mitochondrial reactive oxygen species are essential for skin and hair development.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Nilotinib can cause keratosis pilaris, a skin condition.

Compound 15a was effective in inhibiting 5α-reductase.

Fermented papaya and mangosteen in hair care products helped prevent hair loss and improve hair thickness.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Eclipta alba flavonoids may help treat diabetes by effectively inhibiting Aldose reductase.

Eclipta alba extract shows potential as an anticancer agent by inhibiting cancer cell growth and promoting cell death.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.